Grading disorder severity and averted burden by access to treatment within the GBD framework: a case study with anxiety disorders
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Global Burden of Disease Study (GBD) estimates burden by cause with major relevance for resource allocators globally. Non-fatal burden estimates are influenced by disorder severity. However, for many disorders, global severity is sourced from a single high-income country survey. We aimed to estimate severity distributions that vary by Healthcare Access Quality Index (HAQI) using anxiety disorders as a case study and present the usefulness of this method in simulating averted and avoidable burden globally. METHODS: In this case study, we estimated treatment use among respondents with anxiety disorder in the 1997 Australian National Survey of Mental Health and Wellbeing (NSMHWB), the source used to estimate severity of anxiety disorders in GBD. Treatment effects were sourced from the Cochrane Database of Systematic Reviews and pooled via network meta-analysis. Severity distribution was established via a meta-regression of their disability weights, derived from 12-item short form survey scores. We simulated the shift in severity across scenarios without access to treatment and with full access to optimal treatment (cognitive behavioural therapy and antidepressants). We interpolated this shift linearly along the HAQI, extrapolated country-specific severity from HAQI scores, and calculated averted and avoidable burden. FINDINGS: The database review sourced 56 reviews, of which eight were eligible for inclusion. These eight reviews reported on 156 randomised controlled trials, with 194 treatment effects. Respondents to the 1997 NSMHWB consisted of 5936 women (55·8%) and 4705 (44·2%) men aged 18 years or older (mean age and ethnicity data not available). The survey-weighted treatment effect size was -0·28 (95% uncertainty interval -0·45 to -0·12). The pooled treatment effect for full coverage optimal treatment was -1·07 (-1·47 to -0·64). The sequela-weighted disability weight among people with anxiety disorder in the NSMHWB was 0·141 (0·042 to 0·275). The estimated disability weight was 0·188 (0·070 to 0·341) after removing the benefits of treatment and 0·056 (0·013 to 0·140) after providing all people with anxiety disorder access to optimal treatment. Globally, 12·5% (4·6 to 21·5) of anxiety disorder burden was averted because of available treatment. However, 71·1% (46·2 to 87·6) of global anxiety disorder burden could be averted if all people with anxiety disorders had access to optimal treatment. INTERPRETATION: Because it is based on guidance from a single survey done in one high-income country, the burden of anxiety disorders in low-income and middle-income countries is probably underestimated by GBD. Despite the availability of effective treatments, low use of these treatments means that most burden is still avoidable. Most of the burden could be averted if all people with anxiety disorders had access to optimal treatment, highlighting the importance of public promotion and referral pathways of treatment for anxiety disorders. Location-specific severity distributions in GBD would greatly increase precision in burden estimates and highlight avertable burden to clinicians, public health practitioners, and policy makers. FUNDING: Queensland Health and Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
Self-citationAnalysis of Complex Survey Samples
Lumley, T. (2004) · Journal of Statistical Software · doi:10.18637/jss.v009.i08 · Cited by 2,425
How mental health care should change as a consequence of the COVID-19 pandemic
Moreno, C., Wykes, T., Galderisi, S., Nordentoft, M., Crossley, N., Jones, N., Cannon, M., Correll, C. U., Byrne, L., Carr, S., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30307-2 · Cited by 1,840
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322
Self-citationDisability weights for the Global Burden of Disease 2013 study
Salomon, J. A., Haagsma, J. A., Davis, A., de Noordhout, C. M., Polinder, S., Havelaar, A. H., Cassini, A., Devleesschauwer, B., Kretzschmar, M., Speybroeck, N., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00069-8 · Cited by 1,217
Self-citationNetwork meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J., Abdelalim, A., Abebe, Z., Abebo, T. A., Aboyans, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30994-2 · Cited by 1,013
Self-citationPatel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00390-6 · Cited by 889
Self-citationKola, L., Kohrt, B. A., Hanlon, C., Naslund, J. A., Sikander, S., Balaji, M., Benjet, C., Cheung, E. Y. L., Eaton, J., Gonsalves, P., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00025-0 · Cited by 835
Research works printed but not linked: 12
- Vos, 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 · DOI · Paper page
- Burstein, 2015, Estimating distributions of health state severity for the Global Burden of Disease study, Popul Health Metr, 13, 31, 10.1186/s12963-015-0064-y · DOI · Paper page
- Ferrari, 2013, Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease study 2010, PLoS Med, 10, 10.1371/journal.pmed.1001547 · DOI · Paper page
- Skinner, 2022, Population mental health improves with increasing access to treatment: evidence from a dynamic modelling analysis, BMC Psychiatry, 22, 692, 10.1186/s12888-022-04352-w · DOI
- Ware, 1996, A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity, Med Care, 34, 220, 10.1097/00005650-199603000-00003 · DOI · Paper page
- Alonso, 2018, Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries, Depress Anxiety, 35, 195, 10.1002/da.22711 · DOI · Paper page
- Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package, J Stat Software, 36, 48, 10.18637/jss.v036.i03 · DOI · Paper page
- Aravkin, 2019, Trimmed statistical estimation via variance reduction, Math Oper Res, 45, 292, 10.1287/moor.2019.0992 · DOI
- Vos, 2012, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2163, 10.1016/S0140-6736(12)61729-2 · DOI · Paper page
- Campion, 2020, Addressing the public mental health challenge of COVID-19, Lancet Psychiatry, 7, 657, 10.1016/S2215-0366(20)30240-6 · DOI · Paper page
- Revicki, 2008, Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder, Qual Life Res, 17, 1285, 10.1007/s11136-008-9406-6 · DOI · Paper page
- Ohrnberger, 2020, Validation of the SF12 mental and physical health measure for the population from a low-income country in sub-Saharan Africa, Health Qual Life Outcomes, 18, 78, 10.1186/s12955-020-01323-1 · DOI
Cited by
Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00757-8 · Cited by 5,112
Self-citationHay, S. I., Ong, K. L., Santomauro, D. F., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abate, B. B., Abbafati, C., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01637-x · Cited by 916
Self-citationSantomauro, D. F., Vos, T., Whiteford, H. A., Chisholm, D., Saxena, S., & Ferrari, A. J. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00317-1 · Cited by 57
Self-citationSantomauro, D. F., Miller, P. A., Shadid, J., Wulf Hanson, S., Vo, A., Roy, D. J., Hagins, H., Mantilla Herrera, A. M., Scott, J. G., Erskine, H. E., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00519-2 · Cited by 83
Self-citation
Metadata
- Authors
- Santomauro, D. F., Purcell, C., Whiteford, H. A., Ferrari, A. J., & Vos, T.
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 10
- Issue
- 4
- Pages
- 272-281
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W4324319047
- Cited by
- 24
- References
- 17
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Queensland Government
- Tasmanian Department of Health
- Bill and Melinda Gates Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Grading disorder severity and averted burden by access to treatment within the GBD framework: a case study with anxiety disorders. https://app.cochat.ai/papers/10.1016/s2215-0366(23)00037-8
- The paper
- Santomauro, D. F., Purcell, C., Whiteford, H. A., Ferrari, A. J., & Vos, T. (2023). Grading disorder severity and averted burden by access to treatment within the GBD framework: a case study with anxiety disorders. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(23)00037-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.